Last 12 months
Inside the activity.
0 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 06, 2013 Filed Nov 8, 2013 21:07 UTC |
WELDON WILLIAM CDirector
|
GrantShare Credits · Derivative | 1,526.5383 | $63.87 Strike: $0.00 | $97,500.00 |
DisclosureSEC source: 0001127602-13-031078 · form4.xml · derivative · entry 2 WELDON WILLIAM C · CIK 0001189019 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,234.7749 Underlying: Common Stock · 1,526.5383 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 06, 2013 Filed Nov 8, 2013 21:10 UTC |
DORMAN DAVID WDirector
|
GrantCommon Stock | 3,601 | $63.87 | $229,995.87 |
DisclosureSEC source: 0001127602-13-031082 · form4.xml · nonDerivative · entry 1 DORMAN DAVID W · CIK 0001082870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,726 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| November 06, 2013 Filed Nov 8, 2013 21:12 UTC |
Finucane Anne A.Director
|
GrantCommon Stock | 1,526 | $63.87 | $97,465.62 |
DisclosureSEC source: 0001127602-13-031084 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,526 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| November 06, 2013 Filed Nov 8, 2013 21:18 UTC |
MILLON JEAN PIERREDirector
|
GrantCommon Stock | 1,526 | $63.87 | $97,465.62 |
DisclosureSEC source: 0001127602-13-031088 · form4.xml · nonDerivative · entry 1 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,526 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| November 06, 2013 Filed Nov 8, 2013 21:19 UTC |
WHITE TONY LDirector
|
GrantCommon Stock | 1,526 | $63.87 | $97,465.62 |
DisclosureSEC source: 0001127602-13-031091 · form4.xml · nonDerivative · entry 1 WHITE TONY L · CIK 0001171315 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,718 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| November 05, 2013 Filed Nov 7, 2013 21:01 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
Exercise / conversionStock Option · Derivative | 6,029 | $0.00 Strike: $34.96 | $0.00 |
DisclosureSEC source: 0001127602-13-030883 · form4.xml · derivative · entry 5 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,058 Underlying: Common Stock · 6,029 shares Expires 2018-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2012. Read SEC document |
| November 05, 2013 Filed Nov 7, 2013 21:01 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
SaleCommon Stock | 6,029 | $63.50 | $382,841.50 |
DisclosureSEC source: 0001127602-13-030883 · form4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,677.7198 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| November 05, 2013 Filed Nov 7, 2013 21:01 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
Exercise / conversionCommon Stock | 6,029 | $34.96 | $210,773.84 |
DisclosureSEC source: 0001127602-13-030883 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,706.7198 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 18, 2013 Filed Oct 21, 2013 19:52 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
Exercise / conversionStock Option · Derivative | 11,053 | $0.00 Strike: $30.16 | $0.00 |
DisclosureSEC source: 0001127602-13-029551 · form4.xml · derivative · entry 5 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,214 Underlying: Common Stock · 11,053 shares Expires 2020-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 7/19/2013. Read SEC document |
| October 18, 2013 Filed Oct 21, 2013 19:52 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
SaleCommon Stock | 11,053 | $60.50 | $668,706.50 |
DisclosureSEC source: 0001127602-13-029551 · form4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,677.7198 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| October 18, 2013 Filed Oct 21, 2013 19:52 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
Exercise / conversionCommon Stock | 11,053 | $30.16 | $333,358.48 |
DisclosureSEC source: 0001127602-13-029551 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,730.7198 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 11, 2013 Filed Oct 15, 2013 20:14 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
Exercise / conversionStock Option · Derivative | 11,053 | $0.00 Strike: $30.16 | $0.00 |
DisclosureSEC source: 0001127602-13-029304 · form4.xml · derivative · entry 5 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,267 Underlying: Common Stock · 11,053 shares Expires 2020-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 7/19/2013. Read SEC document |
| October 11, 2013 Filed Oct 15, 2013 20:14 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
SaleCommon Stock | 11,053 | $59.50 | $657,653.50 |
DisclosureSEC source: 0001127602-13-029304 · form4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,677.7198 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| October 11, 2013 Filed Oct 15, 2013 20:14 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
Exercise / conversionCommon Stock | 11,053 | $30.16 | $333,358.48 |
DisclosureSEC source: 0001127602-13-029304 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,730.7198 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2013 Filed Oct 1, 2013 20:19 UTC |
COSBY MARKEVP & President-CVS/pharmacy
|
Exercise / conversionStock Option · Derivative | 115,006 | $0.00 Strike: $35.78 | $0.00 |
DisclosureSEC source: 0001127602-13-028171 · form4.xml · derivative · entry 5 COSBY MARK · CIK 0001214180 · EVP & President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,503 Underlying: Common Stock · 115,006 shares Expires 2018-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in three equal installments, commencing 9/1/2012. Read SEC document |
| September 30, 2013 Filed Oct 1, 2013 20:19 UTC |
COSBY MARKEVP & President-CVS/pharmacy
|
SaleCommon Stock | 26,888 | $57.37 | $1,542,685.56 |
DisclosureSEC source: 0001127602-13-028171 · form4.xml · nonDerivative · entry 3 COSBY MARK · CIK 0001214180 · EVP & President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,955 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F3 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $57.22 and $57.55 per share. Read SEC document |
| September 30, 2013 Filed Oct 1, 2013 20:19 UTC |
COSBY MARKEVP & President-CVS/pharmacy
|
SaleCommon Stock | 115,006 | $57.38 | $6,598,503.75 |
DisclosureSEC source: 0001127602-13-028171 · form4.xml · nonDerivative · entry 2 COSBY MARK · CIK 0001214180 · EVP & President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,843 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $57.20 and $57.58 per share. Read SEC document |
| September 30, 2013 Filed Oct 1, 2013 20:19 UTC |
COSBY MARKEVP & President-CVS/pharmacy
|
Exercise / conversionCommon Stock | 115,006 | $35.78 | $4,114,914.68 |
DisclosureSEC source: 0001127602-13-028171 · form4.xml · nonDerivative · entry 1 COSBY MARK · CIK 0001214180 · EVP & President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,849 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 25, 2013 Filed Sep 27, 2013 21:46 UTC |
DEPARLE NANCY ANNDirector
|
GrantCommon Stock | 562 | $57.78 | $32,472.36 |
DisclosureSEC source: 0001127602-13-027940 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 562 F1 · shares: Consists of common stock issued as a pro rata portion of the retainer payable for the Reporting Person's 2013 Board service. Read SEC document |
| September 13, 2013 Filed Sep 13, 2013 20:05 UTC |
Foulkes HelenaExecutive Vice President
|
Exercise / conversionStock Option · Derivative | 40,734 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-13-027132 · form4.xml · derivative · entry 10 Foulkes Helena · CIK 0001429996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,734 shares Expires 2017-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2011. Read SEC document |
| September 13, 2013 Filed Sep 13, 2013 20:05 UTC |
Foulkes HelenaExecutive Vice President
|
SaleCommon Stock | 40,734 | $60.00 | $2,444,040.00 |
DisclosureSEC source: 0001127602-13-027132 · form4.xml · nonDerivative · entry 4 Foulkes Helena · CIK 0001429996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,816.6021 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| September 13, 2013 Filed Sep 13, 2013 20:05 UTC |
Foulkes HelenaExecutive Vice President
|
Exercise / conversionCommon Stock | 40,734 | $36.23 | $1,475,792.82 |
DisclosureSEC source: 0001127602-13-027132 · form4.xml · nonDerivative · entry 3 Foulkes Helena · CIK 0001429996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,550.6021 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2013 Filed Sep 13, 2013 20:05 UTC |
Foulkes HelenaExecutive Vice President
|
Exercise / conversionStock Option · Derivative | 12,812 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-13-027132 · form4.xml · derivative · entry 9 Foulkes Helena · CIK 0001429996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,734 Underlying: Common Stock · 12,812 shares Expires 2017-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2011. Read SEC document |
| September 12, 2013 Filed Sep 13, 2013 20:05 UTC |
Foulkes HelenaExecutive Vice President
|
SaleCommon Stock | 12,812 | $60.00 | $768,720.00 |
DisclosureSEC source: 0001127602-13-027132 · form4.xml · nonDerivative · entry 2 Foulkes Helena · CIK 0001429996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,816.6021 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| September 12, 2013 Filed Sep 13, 2013 20:05 UTC |
Foulkes HelenaExecutive Vice President
|
Exercise / conversionCommon Stock | 12,812 | $36.23 | $464,178.76 |
DisclosureSEC source: 0001127602-13-027132 · form4.xml · nonDerivative · entry 1 Foulkes Helena · CIK 0001429996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,628.6021 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 09, 2013 Filed Sep 11, 2013 20:19 UTC |
Foulkes HelenaExecutive Vice President
|
Exercise / conversionStock Option · Derivative | 47,568 | $0.00 Strike: $41.17 | $0.00 |
DisclosureSEC source: 0001127602-13-026980 · form4.xml · derivative · entry 7 Foulkes Helena · CIK 0001429996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 47,568 shares Expires 2015-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2009. Read SEC document |
| September 09, 2013 Filed Sep 11, 2013 20:19 UTC |
Foulkes HelenaExecutive Vice President
|
SaleCommon Stock | 47,568 | $58.65 | $2,789,863.20 |
DisclosureSEC source: 0001127602-13-026980 · form4.xml · nonDerivative · entry 2 Foulkes Helena · CIK 0001429996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,816.6021 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| September 09, 2013 Filed Sep 11, 2013 20:19 UTC |
Foulkes HelenaExecutive Vice President
|
Exercise / conversionCommon Stock | 47,568 | $41.17 | $1,958,374.56 |
DisclosureSEC source: 0001127602-13-026980 · form4.xml · nonDerivative · entry 1 Foulkes Helena · CIK 0001429996 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,384.6021 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 05, 2013 Filed Jan 3, 2014 21:26 UTC |
Roberts Jonathan CEVP & President, Caremark
|
GiftCommon Stock | 850 | $58.46 | $49,691.00 |
DisclosureSEC source: 0001127602-14-000798 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,228.6731 Read SEC document |
| September 04, 2013 Filed Sep 5, 2013 20:00 UTC |
Sussman AndrewSVP & President, MinuteClinic
|
Exercise / conversionStock Option · Derivative | 9,020 | $0.00 Strike: $36.96 | $0.00 |
DisclosureSEC source: 0001127602-13-026693 · form4.xml · derivative · entry 6 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,020 Underlying: Common Stock · 9,020 shares Expires 2019-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 9/1/2012. Read SEC document |
| September 04, 2013 Filed Sep 5, 2013 20:00 UTC |
Sussman AndrewSVP & President, MinuteClinic
|
SaleCommon Stock | 9,020 | $58.36 | $526,398.18 |
DisclosureSEC source: 0001127602-13-026693 · form4.xml · nonDerivative · entry 2 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,962.8394 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| September 04, 2013 Filed Sep 5, 2013 20:00 UTC |
Sussman AndrewSVP & President, MinuteClinic
|
Exercise / conversionCommon Stock | 9,020 | $36.96 | $333,379.20 |
DisclosureSEC source: 0001127602-13-026693 · form4.xml · nonDerivative · entry 1 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,982.8394 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2013 Filed Sep 3, 2013 19:54 UTC |
COSBY MARKEVP & President-CVS/pharmacy
|
Tax withholdingCommon Stock | 20,098 | $58.05 | $1,166,688.90 |
DisclosureSEC source: 0001127602-13-026437 · form4.xml · nonDerivative · entry 1 COSBY MARK · CIK 0001214180 · EVP & President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,843 F1 · shares: Surrender of shares in payment of withholding taxes due. Read SEC document |
| August 12, 2013 Filed Jan 3, 2014 23:14 UTC |
Denton David MEVP, CFO
|
GiftCommon Stock | 840 | $59.88 | $50,299.20 |
DisclosureSEC source: 0001127602-14-001016 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,476.0559 Read SEC document |
| May 09, 2013 Filed May 10, 2013 20:21 UTC |
BROWN C DAVID IIDirector
|
GrantShare Credits · Derivative | 2,435.2061 | $57.49 Strike: $0.00 | $140,000.00 |
DisclosureSEC source: 0001127602-13-016463 · form4.xml · derivative · entry 1 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,464.1517 Underlying: Common Stock · 2,435.2061 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 09, 2013 Filed May 10, 2013 20:22 UTC |
SWIFT RICHARD JDirector
|
GrantShare Credits · Derivative | 1,859.019 | $57.49 Strike: $0.00 | $106,875.00 |
DisclosureSEC source: 0001127602-13-016464 · form4.xml · derivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,248.6363 Underlying: Common Stock · 1,859.019 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 09, 2013 Filed May 10, 2013 20:24 UTC |
WELDON WILLIAM CDirector
|
GrantShare Credits · Derivative | 1,695.9471 | $57.49 Strike: $0.00 | $97,500.00 |
DisclosureSEC source: 0001127602-13-016466 · form4.xml · derivative · entry 1 WELDON WILLIAM C · CIK 0001189019 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,695.9471 Underlying: Common Stock · 1,695.9471 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 09, 2013 Filed May 10, 2013 20:28 UTC |
DORMAN DAVID WDirector
|
GrantCommon Stock | 4,000 | $57.49 | $229,960.00 |
DisclosureSEC source: 0001127602-13-016470 · form4.xml · nonDerivative · entry 1 DORMAN DAVID W · CIK 0001082870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,125 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| May 09, 2013 Filed May 10, 2013 20:30 UTC |
Finucane Anne A.Director
|
GrantCommon Stock | 1,695 | $57.49 | $97,445.55 |
DisclosureSEC source: 0001127602-13-016472 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,695 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| May 09, 2013 Filed May 10, 2013 20:32 UTC |
WILLIAMS KRISTEN GIBNEYDirector
|
GrantCommon Stock | 1,695 | $57.49 | $97,445.55 |
DisclosureSEC source: 0001127602-13-016473 · form4.xml · nonDerivative · entry 1 WILLIAMS KRISTEN GIBNEY · CIK 0001197683 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,695 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| May 09, 2013 Filed May 10, 2013 20:34 UTC |
MILLON JEAN PIERREDirector
|
GrantCommon Stock | 1,695 | $57.49 | $97,445.55 |
DisclosureSEC source: 0001127602-13-016477 · form4.xml · nonDerivative · entry 1 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,695 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| May 09, 2013 Filed May 10, 2013 20:36 UTC |
WHITE TONY LDirector
|
GrantCommon Stock | 1,695 | $57.49 | $97,445.55 |
DisclosureSEC source: 0001127602-13-016479 · form4.xml · nonDerivative · entry 1 WHITE TONY L · CIK 0001171315 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,192 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| April 15, 2013 Filed Apr 16, 2013 20:33 UTC |
Finucane Anne A.Director
|
SaleCommon Stock | 500 | $57.24 | $28,620.00 |
DisclosureSEC source: 0001127602-13-013973 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Finucane Family Trust Disclosed balance after: 11,283 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 15, 2013 Filed Apr 16, 2013 20:35 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
Exercise / conversionStock Option · Derivative | 70,773 | $0.00 Strike: $28.26 | $0.00 |
DisclosureSEC source: 0001127602-13-013975 · form4.xml · derivative · entry 11 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,387 Underlying: Common Stock · 70,773 shares Expires 2018-11-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 11/17/2011. Read SEC document |
| April 15, 2013 Filed Apr 16, 2013 20:35 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
Exercise / conversionStock Option · Derivative | 34,423 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-13-013975 · form4.xml · derivative · entry 10 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,423 shares Expires 2017-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2011. Read SEC document |
| April 15, 2013 Filed Apr 16, 2013 20:35 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
Exercise / conversionStock Option · Derivative | 34,422 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-13-013975 · form4.xml · derivative · entry 9 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,423 Underlying: Common Stock · 34,422 shares Expires 2017-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2011. Read SEC document |
| April 15, 2013 Filed Apr 16, 2013 20:35 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
SaleCommon Stock | 70,773 | $57.34 | $4,058,123.82 |
DisclosureSEC source: 0001127602-13-013975 · form4.xml · nonDerivative · entry 6 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,061.1502 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 15, 2013 Filed Apr 16, 2013 20:35 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
Exercise / conversionCommon Stock | 70,773 | $28.26 | $2,000,044.98 |
DisclosureSEC source: 0001127602-13-013975 · form4.xml · nonDerivative · entry 5 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,834.1502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2013 Filed Apr 16, 2013 20:35 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
SaleCommon Stock | 34,423 | $57.22 | $1,969,684.06 |
DisclosureSEC source: 0001127602-13-013975 · form4.xml · nonDerivative · entry 4 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,061.1502 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 15, 2013 Filed Apr 16, 2013 20:35 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
Exercise / conversionCommon Stock | 34,423 | $36.23 | $1,247,145.29 |
DisclosureSEC source: 0001127602-13-013975 · form4.xml · nonDerivative · entry 3 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,484.1502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.